Ketamine Induces Lasting Antidepressant Effects by Modulating the NMDAR/CaMKII-Mediated Synaptic Plasticity of the Hippocampal Dentate Gyrus in Depressive Stroke Model

Copyright © 2021 Idriss Ali Abdoulaye et al.

Bibliographische Detailangaben
Veröffentlicht in:Neural plasticity. - 1998. - 2021(2021) vom: 30., Seite 6635084
1. Verfasser: Abdoulaye, Idriss Ali (VerfasserIn)
Weitere Verfasser: Wu, Shan-Shan, Chibaatar, Enkhmurun, Yu, Da-Fan, Le, Kai, Cao, Xue-Jin, Guo, Yi-Jing
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2021
Zugriff auf das übergeordnete Werk:Neural plasticity
Schlagworte:Journal Article Research Support, Non-U.S. Gov't Antidepressive Agents Disks Large Homolog 4 Protein Dlg4 protein, rat Receptors, N-Methyl-D-Aspartate Ketamine 690G0D6V8H Calcium-Calmodulin-Dependent Protein Kinase Type 2 EC 2.7.11.17
Beschreibung
Zusammenfassung:Copyright © 2021 Idriss Ali Abdoulaye et al.
Background: Ketamine has been shown to possess lasting antidepressant properties. However, studies of the mechanisms involved in its effects on poststroke depression are nonexistent
Methods: To investigate these mechanisms, Sprague-Dawley rats were treated with a single local dose of ketamine after middle cerebral artery occlusion and chronic unpredicted mild stress. The effects on the hippocampal dentate gyrus were analyzed through assessment of the N-methyl-D-aspartate receptor/calcium/calmodulin-dependent protein kinase II (NMDAR/CaMKII) pathway, synaptic plasticity, and behavioral tests
Results: Ketamine administration rapidly exerted significant and lasting improvements of depressive symptoms. The biochemical analysis showed rapid, selective upregulation and downregulation of the NMDAR2-β and NMDAR2-α subtypes as well as their downstream signaling proteins β-CaMKII and α-phosphorylation in the dentate gyrus, respectively. Furthermore, the colocalization analysis indicated a significant and selectively increased conjunction of β-CaMKII and postsynaptic density protein 95 (PSD95) coupled with a notable decrease in NMDAR2-β association with PSD95 after ketamine treatment. These changes translated into significant and extended synaptic plasticity in the dentate gyrus
Conclusions: These findings not only suggest that ketamine represents a viable candidate for the treatment of poststroke depression but also that ketamine's lasting antidepressant effects might be achieved through modulation of NMDAR/CaMKII-induced synaptic plasticity in key brain regions
Beschreibung:Date Completed 06.12.2021
Date Revised 16.07.2022
published: Electronic-eCollection
Citation Status MEDLINE
ISSN:1687-5443
DOI:10.1155/2021/6635084